比较分析α-糜蛋白与尿激酶雾化吸入在支气管扩张治疗中的应用效果
2014-08-08朱勇陈华良
朱勇+陈华良
[摘要] 目的 比较分析α-糜蛋白与尿激酶雾化吸入在支气管扩张治疗中的应用效果。 方法 选择2011年5月~2013年1月葛洲坝中心医院治疗的支气管扩张患者50例,随机分为观察组和对照组,每组各25例。对照组患者给予α-糜蛋白雾化吸入治疗,观察组患者给予尿激酶雾化吸入治疗,对两组患者临床疗效及治疗前后动脉血气指标进行分析比较。 结果 ①观察组患者治愈率为32.0%,总有效率为96.0%;对照组患者治愈率为24.0%,总有效率为80.0%;观察组患者的治愈率和总有效率均明显高于对照组,差异有统计学意义(P < 0.05)。②治疗后观察组PaCO2水平[(40.4±8.4)mm Hg]明显低于对照组[(48.2±9.0)mm Hg],PaO2水平[(86.6±11.2)mm Hg]明显高与对照组[(72.4±10.5)mm Hg] ,差异有统计学意义(P < 0.05)。 结论 尿激酶较α-糜蛋白雾化吸入在支气管扩张治疗中具有较好的应用效果,值得推广。
[关键词] α-糜蛋白;尿激酶;雾化吸入;支气管扩张
[中图分类号] R562.2[文献标识码] A[文章编号] 1673-7210(2014)04(c)-0028-05
Comparative analysis of effects of α-chymotrypsin and Urokinase aerosol inhalation in the treatment of bronchodilator
ZHU Yong1 CHEN Hualiang2
1.Department of Internal Medicine, Gezhouba Dam Central Hospital, Hubei Province, Yichang 443002, China; 2.The Ninth Hospital of Ningbo City, Zhejiang Province, Ningbo 315000, China
[Abstract] Objective To compare and analyze the effects of α-chymotrypsin and Urokinase aerosol inhalation in the treatment of bronchodilator. Methods 50 cases of bronchiectasis patients in Gezhouba Dam Central Hospital from May 2011 to January 2013 were selected, they were randomly assigned into the observation group and the control group based on the principles with 25 cases in each group. Patients of the control group were given α-chymotrypsin aerosol inhalation treatment, patients of the observation group were given Urokinase aerosol inhalation, and then the clinical efficacy, before and after treatment of arterial blood gas of the two groups of patients were analyzed and compared. Results ①The cure rate of patients in the observation group was 32%, the total effective rate was 96%; the cure rate of patients in the control group was 24%, the total effective rate was 80%. The cure rate and the total effective rate of patients in the observation group were all higher than those of the control group, the differences were statistically significant (P < 0.05). ②After treatment, the PCO2 level of patients in the observation group [(40.4±8.4) mm Hg] was lower than that in control group [(48.2±9.0) mm Hg], the PO2 level in observation group [(86.6±11.2) mmHg] was higher than that in control group [(72.4±10.5) mm Hg], the differences were statistically significant (P < 0.05). Conclusion The effect of Urokinase aerosol inhalation is better than α-chymotrypsin aerosol inhalation in the treatment of bronchodilator, so it is worthy of promotion.
[Key words] α-chymotrypsin; Urokinase; Aerosol inhalation; Bronchiectasis
支气管扩张是呼吸系统常见的化脓性炎症,属于一种不可逆性扩张,发生原因是一支或多支近端支气管及中等大小支气管管壁组织破坏。在治疗支气管扩张患者的过程中,一个关键的步骤就是对感染进行有效的控制,并雾化排痰。α-糜蛋白能够对气管及支气管内蛋白分泌物进行有效的清除,尿激酶能够对纤维蛋白进行有效的溶解[1]。本研究支气管扩张患者的临床资料进行了回顾性分析,比较分析了α-糜蛋白与尿激酶雾化吸入在支气管扩张治疗中的应用效果,现报道如下:
1 资料与方法
1.1 一般资料……p>
